What is the main business of Ambercell Poland?

The main business activity of Ambercell Poland focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 14, 2022.

Where is the headquarters located?

The headquarters is located at: ul. Grzybowska 80/82, 00-844 Warszawa.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

In 2025, the company generated total revenue of USD 474,888, representing a decrease of 8.6% compared to 2024.

Is the company profitable?

Yes, the company recorded a net profit of USD 4,129 in 2025, meaning the company decreased its profit by 59.9%.

Which cost dominates operating expenses?

The largest operating cost category falls under other operating costs. This category amounted to USD 464,005 in 2025, representing 100% of all operating expenses.

Ambercell Polandsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-03-14

Share capital

5,000.00 PLN

Registered address

ul. Grzybowska 80/82/128, 00-844 Warszawa, Poland

Financials

Revenue history (in k)

Filing timeliness

4 of 4 financial statements were filed late (the longest delay 1173 days for 2022).

202502/10/2026
202402/10/2026
202330/09/2026
202230/09/2026

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 474.89kMedianUSD 1.07mAverageUSD 22.38m

Net profit

This companyUSD 4.13kMedianUSD 37.33kAverageUSD 879.18k

Operating costs

This companyUSD 464.00kMedianUSD 926.31kAverageUSD 21.06m

Assets

This companyUSD 107.99kMedianUSD 609.81kAverageUSD 11.84m

Industry

Authorized Representatives

Vaida Gražienė – President of the Management Board

Manner of representation

In the case of a one-person management board, the company is represented independently by the President of the Management Board. In the case of a multi-member management board, the company is represented independently by the President of the Management Board, or by two members of the management board jointly, or by a member of the management board jointly with a commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Ambercell Solutions, Uab	100	$1,350.62	100%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2022-01-08.

PKO Bank Polski
85 1020 1013 0000 0802 0474 8358

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
PUBE Globalsp. z o.o.	$1,777,827.09	pubeglobal.com
Tricopat Globalsp. z o.o.	$1,772,824.41	tricopatglobal.com
Novicaresp. z o.o.	$1,512,398.66	novicare.pl
Novisc Pharmasp. z o.o.	$806,018.56	novisc.com
Goodwill Pharma Polskasp. z o.o.	$664,724.30	goodwillpharma.com
Dental Solutionssp. z o.o.	$611,683.37	dentalsolutions.pl
Beauty Care Solutionsp. z o.o.	$391,209.94	ohhira.pl
Aimedicalsp. z o.o.	$240,059.72	aimedical.pl
Vorwarts Pharmasp. z o.o.	$210,138.62	vorwartspharma.pl
Mitramed Paweł Wysocki, Piotr Wachaczyksp. j.	$198,282.96	e.pl

Change history

Date	Event
2025-11-03	Switch to PKD 2025 (6 PKD 2007 codes → 6 PKD 2025 codes)
2022-03-14	Entered in the register

FAQ

Last updated: 2026-10-03